,for, Item ID-
  • #1081079
  • Providers like you icon
  • Glaxo Smith Kline #58160082311

Shingrix® Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection 0.5 mL

SHINGRIX VACC, SDV 50MCG/0.5ML0.5ML (10/BX)

Glaxo Smith Kline 58160082311
Glaxo Smith Kline 58160082311
Shingrix® Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection 0.5 mL
Shingrix® Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection 0.5 mL
Compare

Features

  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy
  • More …
  Log In to Order
or
 View Alternatives

Product Specifications

Features
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • A single dose after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
  • 10 Doses
More Information
Compare Products (0) Clear Compare